Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Underweight | Research

Nomogram for predicting the overall survival of underweight patients with colorectal cancer: a clinical study

Authors: Jun Woo Bong, Younghyun Na, Yeonuk Ju, Chinock Cheong, Sanghee Kang, Sun Il Lee, Byung Wook Min

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

An underweight individual is defined as one whose Body Mass Index (BMI) is < 18.5 kg/m2. Currently, the prognosis in patients with colorectal cancer (CRC) who are also underweight is unclear.

Methods

Information on South Korean patients who underwent curative resection for CRC without distant metastasis was collected from health insurance registry data between January 2014 and December 2016. We compared the overall survival (OS) of underweight and non-underweight (BMI ≥ 18.5 kg/m2) patients after adjusting for confounders using propensity score matching. A nomogram to predict OS in the underweight group was constructed using the significant risk factors identified in multivariate analysis. The predictive and discriminative capabilities of the nomogram for predicting 3- and 5-year OS in the underweight group were validated and compared with those of the tumor, node, and metastasis (TNM) staging system in the training and validation sets.

Results

A total of 23,803 (93.6%) and 1,644 (6.4%) patients were assigned to the non-underweight and underweight groups, respectively. OS was significantly worse in the underweight group than in the non-underweight group for each pathological stage (non-underweight vs. underweight: stage I, 90.1% vs. 77.1%; stage IIA, 85.3% vs. 67.3%; stage IIB/C, 74.9% vs. 52.1%; and stage III, 73.2% vs. 59.4%, P < 0.001). The calibration plots demonstrated that the nomogram exhibited satisfactory consistency with the actual results. The concordance index (C-index) and area under the receiver operating characteristic curve (AUC) of the nomogram exhibited better discriminatory capability than those of the TNM staging system (C-index, nomogram versus TNM staging system: training set, 0.713 versus 0.564, P < 0.001; validation set, 0.691 versus 0.548, P < 0.001; AUC for 3- and 5- year OS, nomogram versus TNM staging system: training set, 0.748 and 0.741 versus 0.610 and 0.601; validation set, 0.715 and 0.753 versus 0.586 and 0.579, respectively).

Conclusions

Underweight patients had worse OS than non-underweight patients for all stages of CRC. Our nomogram can guide prognostic predictions and the treatment plan for underweight patients with CRC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sargent D, Sobreto A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872–7.CrossRefPubMedPubMedCentral Sargent D, Sobreto A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872–7.CrossRefPubMedPubMedCentral
2.
go back to reference Sung H, Ferlay J, Siegel R, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, Ferlay J, Siegel R, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
3.
go back to reference Yu C, Zhang Y. Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis. BMC Gastroenterol. 2020;20(1):347.CrossRefPubMedPubMedCentral Yu C, Zhang Y. Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis. BMC Gastroenterol. 2020;20(1):347.CrossRefPubMedPubMedCentral
4.
go back to reference Kou FR, Zhang YZ, Xu WR. Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients. World J Clin Cases. 2021;9(11):2503–18.CrossRefPubMedPubMedCentral Kou FR, Zhang YZ, Xu WR. Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients. World J Clin Cases. 2021;9(11):2503–18.CrossRefPubMedPubMedCentral
5.
go back to reference Liu LL, Sun JD, Xiang ZL. Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort. BMC Gastroenterol. 2022;22(1):446.CrossRefPubMedPubMedCentral Liu LL, Sun JD, Xiang ZL. Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort. BMC Gastroenterol. 2022;22(1):446.CrossRefPubMedPubMedCentral
6.
go back to reference World Health Organization. Regional Office for the Western, P. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000. World Health Organization. Regional Office for the Western, P. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
7.
go back to reference Park SW, Lee DW, Park JW, et al. Impact of body mass index on overall survival after surgery for colorectal cancer. Korean J Clin Oncol. 2016;12(2):91–6.CrossRef Park SW, Lee DW, Park JW, et al. Impact of body mass index on overall survival after surgery for colorectal cancer. Korean J Clin Oncol. 2016;12(2):91–6.CrossRef
8.
go back to reference Kalb M, Langheinrich M, Merkel S, et al. Influence of body mass index on long-term outcome in patients with rectal Cancer-A single centre experience. Cancers (Basel). 2019;11(5). Kalb M, Langheinrich M, Merkel S, et al. Influence of body mass index on long-term outcome in patients with rectal Cancer-A single centre experience. Cancers (Basel). 2019;11(5).
9.
go back to reference Kim JA, Yoon S, Kim LY, et al. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: Strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–28.CrossRefPubMedPubMedCentral Kim JA, Yoon S, Kim LY, et al. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: Strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–28.CrossRefPubMedPubMedCentral
10.
go back to reference Yildirim BA, Ozdemir Y, Colakoglu T, et al. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy. Pancreatology. 2016;16(4):599–604.CrossRefPubMed Yildirim BA, Ozdemir Y, Colakoglu T, et al. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy. Pancreatology. 2016;16(4):599–604.CrossRefPubMed
11.
go back to reference Warner ET, Ballman KV, Strand C, et al. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat. 2016;159(1):109–18.CrossRefPubMedPubMedCentral Warner ET, Ballman KV, Strand C, et al. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat. 2016;159(1):109–18.CrossRefPubMedPubMedCentral
12.
13.
go back to reference Ock CY, Oh DY, Lee J, et al. Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer. Gastric Cancer. 2016;19(2):597–606.CrossRefPubMed Ock CY, Oh DY, Lee J, et al. Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer. Gastric Cancer. 2016;19(2):597–606.CrossRefPubMed
14.
go back to reference Wang Y, Beydoun MA. The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28.CrossRefPubMed Wang Y, Beydoun MA. The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6–28.CrossRefPubMed
16.
go back to reference Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107(8):1175–85.CrossRefPubMed Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107(8):1175–85.CrossRefPubMed
17.
go back to reference Renfro L, Loupakis F, Adams R, et al. Body Mass Index Is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD Database. J Clin Oncol. 2016;34(2):144–50.CrossRefPubMed Renfro L, Loupakis F, Adams R, et al. Body Mass Index Is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD Database. J Clin Oncol. 2016;34(2):144–50.CrossRefPubMed
18.
go back to reference Caan B, Meyerhardt J, Kroenke C, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomark Prev. 2017;26(7):1008–15.CrossRef Caan B, Meyerhardt J, Kroenke C, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomark Prev. 2017;26(7):1008–15.CrossRef
19.
go back to reference Kroenke C, Neugebauer R, Meyerhardt J, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137–45.CrossRefPubMedPubMedCentral Kroenke C, Neugebauer R, Meyerhardt J, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137–45.CrossRefPubMedPubMedCentral
20.
go back to reference Liu H, Wei R, Li C, et al. BMI may be a prognostic factor for local advanced rectal cancer patients treated with long-term neoadjuvant chemoradiotherapy. Cancer Manag Res. 2020;12:10321–32.CrossRefPubMedPubMedCentral Liu H, Wei R, Li C, et al. BMI may be a prognostic factor for local advanced rectal cancer patients treated with long-term neoadjuvant chemoradiotherapy. Cancer Manag Res. 2020;12:10321–32.CrossRefPubMedPubMedCentral
21.
go back to reference Lee J, Meyerhardt J, Giovannucci E, et al. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS ONE. 2015;10(3):e0120706.CrossRefPubMedPubMedCentral Lee J, Meyerhardt J, Giovannucci E, et al. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS ONE. 2015;10(3):e0120706.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Kaneko M, Sasaki S, Ozaki K, et al. Underweight status predicts a poor prognosis in elderly patients with colorectal cancer. Mol Clin Oncol. 2016;5(3):289–94.CrossRefPubMedPubMedCentral Kaneko M, Sasaki S, Ozaki K, et al. Underweight status predicts a poor prognosis in elderly patients with colorectal cancer. Mol Clin Oncol. 2016;5(3):289–94.CrossRefPubMedPubMedCentral
24.
go back to reference Aparicio T, Ducreux M, Faroux R, et al. Overweight is associated to a better prognosis in metastatic colorectal cancer: a pooled analysis of FFCD trials. Eur J Cancer. 2018;98:1–9.CrossRefPubMed Aparicio T, Ducreux M, Faroux R, et al. Overweight is associated to a better prognosis in metastatic colorectal cancer: a pooled analysis of FFCD trials. Eur J Cancer. 2018;98:1–9.CrossRefPubMed
25.
go back to reference Miya T, Goya T, Fujii H, et al. Factors affecting the pharmacokinetics of CPT-11: the body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11. Invest New Drugs. 2001;19(1):61–7.CrossRefPubMed Miya T, Goya T, Fujii H, et al. Factors affecting the pharmacokinetics of CPT-11: the body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11. Invest New Drugs. 2001;19(1):61–7.CrossRefPubMed
26.
go back to reference Steinmeyer Z, Gerad S, Filleron T, et al. Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol. BMC Cancer. 2019;19(1):1153.CrossRefPubMedPubMedCentral Steinmeyer Z, Gerad S, Filleron T, et al. Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol. BMC Cancer. 2019;19(1):1153.CrossRefPubMedPubMedCentral
28.
go back to reference Holroyde CP, Skutches CL, Boden G, et al. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res. 1984;44(12 Pt 1):5910–3.PubMed Holroyde CP, Skutches CL, Boden G, et al. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res. 1984;44(12 Pt 1):5910–3.PubMed
29.
go back to reference Choi MH, Oh SN, Lee IK, et al. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle. 2018;9(1):53–9.CrossRefPubMed Choi MH, Oh SN, Lee IK, et al. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle. 2018;9(1):53–9.CrossRefPubMed
30.
go back to reference Li F, Duan Y, Hu CA, et al. Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue. Cytokine Growth Factor Rev. 2017;33:73–82.CrossRefPubMed Li F, Duan Y, Hu CA, et al. Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue. Cytokine Growth Factor Rev. 2017;33:73–82.CrossRefPubMed
31.
go back to reference Han JS, Ryu H, Park IJ, et al. Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat. 2020;52(2):563–72.CrossRefPubMed Han JS, Ryu H, Park IJ, et al. Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat. 2020;52(2):563–72.CrossRefPubMed
32.
go back to reference Prado CM, Cushen SJ, Orsso CE, et al. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc Nutr Soc. 2016;75(2):188–98.CrossRefPubMed Prado CM, Cushen SJ, Orsso CE, et al. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc Nutr Soc. 2016;75(2):188–98.CrossRefPubMed
33.
go back to reference Sinicrope FA, Foster NR, Yothers G, et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013;119(8):1528–36.CrossRefPubMed Sinicrope FA, Foster NR, Yothers G, et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013;119(8):1528–36.CrossRefPubMed
34.
go back to reference Uratani R, Toiyama Y, Shimura T, et al. Preoperative lower body mass index correlates with poorer prognosis in patients undergoing curative laparoscopic surgery for colorectal cancer. Anticancer Res. 2015;35(10):5639–48.PubMed Uratani R, Toiyama Y, Shimura T, et al. Preoperative lower body mass index correlates with poorer prognosis in patients undergoing curative laparoscopic surgery for colorectal cancer. Anticancer Res. 2015;35(10):5639–48.PubMed
35.
go back to reference Wu X, Lin H, Li S. Prognoses of different pathological subtypes of colorectal cancer at different stages: a population-based retrospective cohort study. BMC Gastroenterol. 2019;19(1):164.CrossRefPubMedPubMedCentral Wu X, Lin H, Li S. Prognoses of different pathological subtypes of colorectal cancer at different stages: a population-based retrospective cohort study. BMC Gastroenterol. 2019;19(1):164.CrossRefPubMedPubMedCentral
36.
go back to reference Korphaisarn K, Morris V, Davis J, et al. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer. 2019;121(6):505–10.CrossRefPubMedPubMedCentral Korphaisarn K, Morris V, Davis J, et al. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer. 2019;121(6):505–10.CrossRefPubMedPubMedCentral
37.
go back to reference Ll Y, Wang M, He P. Clinicopathological characteristics and survival in colorectal signet ring cell carcinoma: a population-based study. Sci Rep. 2020;10(1):10460.CrossRef Ll Y, Wang M, He P. Clinicopathological characteristics and survival in colorectal signet ring cell carcinoma: a population-based study. Sci Rep. 2020;10(1):10460.CrossRef
38.
go back to reference Diao JD, Ma LX, Wu CJ, et al. Construction and validation a nomogram to predict overall survival for colorectal signet ring cell carcinoma. Sci Rep. 2021;11(1):3382.CrossRefPubMedPubMedCentral Diao JD, Ma LX, Wu CJ, et al. Construction and validation a nomogram to predict overall survival for colorectal signet ring cell carcinoma. Sci Rep. 2021;11(1):3382.CrossRefPubMedPubMedCentral
39.
go back to reference Liu W, Zhang M, Wu J, et al. Oncologic outcome and efficacy of chemotherapy in colorectal cancer patients aged 80 years or older. Front Med. 2020;10(7):525421.CrossRef Liu W, Zhang M, Wu J, et al. Oncologic outcome and efficacy of chemotherapy in colorectal cancer patients aged 80 years or older. Front Med. 2020;10(7):525421.CrossRef
40.
go back to reference Chandrasinghe PC, Ediriweera DS, Nazar T, et al. Overall survival of elderly patients having surgery for colorectal cancer is comparable to younger patients: results from a South Asian population. Gastroenterol Res Pract. 2017;2017:9670512.CrossRefPubMedPubMedCentral Chandrasinghe PC, Ediriweera DS, Nazar T, et al. Overall survival of elderly patients having surgery for colorectal cancer is comparable to younger patients: results from a South Asian population. Gastroenterol Res Pract. 2017;2017:9670512.CrossRefPubMedPubMedCentral
41.
go back to reference Song N, Huang D, Jang D, et al. Optimal body mass index cut-off point for predicting colorectal cancer survival in an asian population: a national health information database analysis. Cancers. 2020;12(4):830.CrossRefPubMedPubMedCentral Song N, Huang D, Jang D, et al. Optimal body mass index cut-off point for predicting colorectal cancer survival in an asian population: a national health information database analysis. Cancers. 2020;12(4):830.CrossRefPubMedPubMedCentral
Metadata
Title
Nomogram for predicting the overall survival of underweight patients with colorectal cancer: a clinical study
Authors
Jun Woo Bong
Younghyun Na
Yeonuk Ju
Chinock Cheong
Sanghee Kang
Sun Il Lee
Byung Wook Min
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02669-8

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.